These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33710136)
1. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database. Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136 [TBL] [Abstract][Full Text] [Related]
2. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study. Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008 [TBL] [Abstract][Full Text] [Related]
3. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235 [TBL] [Abstract][Full Text] [Related]
4. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution. Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304 [TBL] [Abstract][Full Text] [Related]
5. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study. Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080 [TBL] [Abstract][Full Text] [Related]
6. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery. Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695 [TBL] [Abstract][Full Text] [Related]
7. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883 [TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant ovarian germ cell tumors and preservation of fertility. Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794 [TBL] [Abstract][Full Text] [Related]
9. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study. Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis]. Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692 [TBL] [Abstract][Full Text] [Related]
12. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study. Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306 [TBL] [Abstract][Full Text] [Related]
13. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis. Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784 [TBL] [Abstract][Full Text] [Related]
14. Component Patterns and Survival Outcomes in Patients with Mixed Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study. Li S; Zhang R; Zhang X; Zhang T; Cao D; Xiang Y; Yang J Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):370-377. PubMed ID: 38555208 [TBL] [Abstract][Full Text] [Related]
15. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases. Xu W; Li Y Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571 [TBL] [Abstract][Full Text] [Related]
16. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN. Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024 [TBL] [Abstract][Full Text] [Related]
17. Trends in the surgical management of malignant ovarian germcell tumors. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791 [TBL] [Abstract][Full Text] [Related]
18. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study. Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403 [TBL] [Abstract][Full Text] [Related]